Drug Diversion

Puts patients at risk for healthcare-associated infections

When prescription medicines are obtained or used illegally, it is called drug diversion. Healthcare providers who steal prescription medicines or controlled substances such as opioids for their own use put patients at risk.

This can result in several types of patient harm, including:

• Substandard care delivered by an impaired healthcare provider
• Denial of essential pain medication or therapy
• Risks of infection (e.g., with hepatitis C virus or bacterial pathogens) if a provider tampers with injectable drugs

Addiction to prescription narcotics has reached epidemic proportions and is a major driver of drug diversion.

Outbreaks Associated with Drug Diversion

CDC and state and local health departments have assisted in the investigation of infection outbreaks stemming from drug diversion activities that involved healthcare providers who tampered with injectable drugs.

U.S. Outbreaks Associated with Drug Diversion by Healthcare Providers, 1983-2018

These outbreaks revealed gaps in prevention, detection, or response to drug diversion in U.S. healthcare facilities. Healthcare facilities should have strong narcotics security measures and active monitoring systems to prevent and detect diversion activities.

Appropriate response by healthcare facilities includes:

• assessment of harm to patients
• consultation with public health officials when tampering with injectable medication is suspected
• prompt reporting to law and other enforcement agencies

Drug Diversion Information for Clinicians

Drug Diversion Handout pdf icon[PDF – 1 page]

Bloodborne Pathogens Training [20:08 mins]

Prevention Resources

• National Association of Drug Diversion Investigatorsexternal icon
• Minnesota Hospital Association Drug Diversion Prevention Toolkitexternal icon
• Drug Diversion in Hospitals: A Guide to Preventing and Investigating Diversion Issues word icon[DOC – 23 pages]external icon
• CDC Public Health Ethics Case Study, Unsafe Injections: Duty to Warn? pdf icon[PDF – 5 pages]
• Premier Inc. Drug Diversion Websiteexternal icon
• Substance Abuse and Mental Health Services Administrationexternal icon
• National Institute on Drug Abuse (NIDA)external icon
• Drug Diversion in Health Care Settings Can Put Patients At Risk for Viral Hepatitisexternal icon (AIDS.gov Blog, May 2, 2014)
• CDC Shares Resources on the Risks of Healthcare-associated Infections from Drug Diversionexternal icon (AIDS.gov Blog, August 25, 2014)
• Drug Diversion in Health Care Settings Can Put Patients At Risk for Viral Hepatitisexternal icon (AIDS.gov Blog, May 2, 2014)

Enforcement Agencies

• Drug Enforcement Administrationexternal icon
• FDA Office of Criminal Investigationsexternal icon

State Health Department Reports

• Minnesota Controlled Substance Diversion Prevention Coalition pdf icon[PDF – 13 pages]external icon
• New Hampshire Hepatitis C Outbreak Report pdf icon[PDF – 176 pages]external icon
• Public Health Vulnerability Review: Drug Diversion, Infection Risk pdf icon[PDF – 55 pages]external icon

Selected Peer-reviewed Publications

• Schuppener, L., Pop-Vicas, A., Brooks, E., Duster, M., Crnich, C., Sterkel, A., . . . Safdar, N. (2017).
  Serratia marcescens Bacteremia: Nosocomial Cluster Following Narcotic Diversion. . Infection Control & Hospital Epidemiology, 1-5.
• Warner AE, Schaefer MK, Patel PR, Drobeniuc J, Xia G, Lin Y, Khudyakov Y, Vonderwahl CW, Miller L, Thompson ND. Outbreak of hepatitis C virus infection associated with narcotics diversion by an hepatitis C virus-infected surgical technician. external icon Am J Infect Control. 2015; 43(1): 53–58.
• Schaefer MK, Perz JF. Outbreaks of infections associated with drug diversion by healthcare personnel, United States external icon. Mayo Clinic Proceedings.2014; 89 (6).
• Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical Overdose Deaths, United States, 2010 external icon. JAMA. 2013; 309(7):657-659.
• Warner DO et. al., Substance Use Disorder Among Anesthesiology Residents, 1975-2009 external icon. JAMA. 2013; 310(21):2289-2296.
• Hellinger WC, Bacalis LP, Kay RS, Thompson ND, Xia GL, Lin Y, Khudyakov YE, Perz JF. Health care–associated hepatitis C virus infections attributed to narcotic diversion external icon. Ann Intern Med. 2012; 156:477-82.
• Berge KH et. al., Diversion of drugs within healthcare facilities, a multiple-victim crime: Patterns of diversion, scope, consequences, detection, and prevention pdf icon[PDF – 323 KB] external icon. Mayo Clin Proc.2012; 87(7):674-682.

Timeline References

1. Njuguna HN, Stinson D, Montgomery P, Turner N, D’Angeli M., Carr J., et Hepatitis C Virus Potentially Transmitted by Opioid Drug Diversion from a Nurse—Washington, August 2017–March 2018. Morbidity and Mortality Weekly Report. 2019; 68(16), 374.
2. Wasiura J, Segal B H, Mullin KM. Cluster of Sphingomonas paucimobilis Bacteremias Linked to Diversion of Intravenous Hydromorphoneexternal icon. N Engl J Med. 2019; 381(6), 584-585.
3. Utah Department of Health. Utah Health Status Update: Hepatitis C and Drug Diversion pdf icon[PDF – 4 pages]external icon. April 2017.
4. Schuppener LM, Pop-Vicas AE, Brooks EG, Duster MN, Crnich CJ, Sterkel AK, et al. Serratia marcescens bacteremia: nosocomial cluster following narcotic diversionexternal icon. Infect Control Hosp Epidemiol. 2017; 38(9), 1027-1031.
5. Maki DG, Klein BS, McCormick RD, et al. Nosocomial Pseudmonas pickettii bacteremias traced to narcotic tampering: a case for selective drug screening of health care personnel. external iconJAMA. 1991;265(8):981-986.
6. Sehulster L, Taylor J, Hendricks K, VanEgdom M, Whitely S, Manning S. Hepatitis C outbreak linked to narcotic tampering in an ambulatory surgical center [Abstract]. Program and Abstracts of the 37th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology. 1997; 293.
7. Ostrowsky BE, Whitener C, Bredenberg HK, et al. Serratia marcescens bacteremia traced to an infused narcotic. external iconN Engl J Med. 2002;346(20):1529-1537.
8. Lee KC, Scoville S, Taylor R, et al. Outbreak of acute hepatitis c virus (HCV) infections of two different genotypes associated with an HCV-infected anesthetist [Abstract]. Poster session at 43rd Annual Infectious Diseases Society of American Annual Conference. San Francisco, CA; October 8, 2005.
9. Schaefer MK, Perz JF. Outbreaks of infections associated with drug diversion by healthcare personnel, United States external icon. Mayo Clinic Proceedings.2014; 89 (6).
10. Behrens-Muller B, Conway J, Yoder J, Conover CS. Investigation and control of an outbreak of Achromobacter xylosoxidans bacteremia. external iconInfect Control Hosp Epidemiol. 2012;33(2):180-184.
11. Hellinger WC, Bacalis LP, Kay RS, Thompson ND, Xia GL, Lin Y, Khudyakov YE, Perz JF. Health care–associated hepatitis C virus infections attributed to narcotic diversion external icon. Ann Intern Med.2012; 156:477-82.
12. Ramer, H. Hepatitis C tests continue after medical tech David Kwiatkowski’s arrest. HuffingtonPost. December 22, 2012.
13. Minnesota Department of Health, Infectious Disease Epidemiology, Prevention and Control Division. Outbreak of gram-negative bacteremia at St. Cloud Hospital. Investigation Summary, Minnesota Department of Health, 2011 pdf icon[PDF – 27 pages] external icon. Sept 14, 2012.
14. New Hampshire Department of Health and Human Services, Division of Public Health Services. State of New Hampshire hepatitis C outbreak investigation Exeter Hospital public report pdf icon[PDF – 176 pages]external icon. June
15. 2012 News Release. State health officials provide update in the case of potential hepatitis C exposures at Hays Medical Centerexternal icon. August 2012.
16. Walker AK. 1,750 had possible contact with technician with hepatitis Cexternal icon. Baltimore Sun. August 12, 2012.